Guo W, Wang S W, Feng C H
Bone Tumor Research Laboratory, People's Hospital, Beijing Medical University.
Zhonghua Wai Ke Za Zhi. 1994 Jul;32(7):412-5.
Immunohistochemical evaluation of 24 osteosarcoma using an anti-p53 protein monoclonal antibody (Moab p53-12) showed strong positive reaction in the nuclei of tumor cells in 14 osteosarcoma (58.3%). Many studies have proved that this overexpression of p53 protein in tumor cells is associated with mutation of the p53 gene. Contrast study with DNA flow cytometry made on osteosarcoma showed that most of the p53 strongly positive tumors have higher DNA Index value than negative or slightly positive ones, though no statistically difference existed between two groups. Southern blot hybridization of p53 gene was also made in osteosarcomas. 5 of 20 cases (20%) had the structural changes of p53 gene. 3 of them were part or whole deletion of the gene. 2 of them had the extra-band, indicating the rearrangement of the gene.
使用抗p53蛋白单克隆抗体(Moab p53 - 12)对24例骨肉瘤进行免疫组化评估,结果显示14例骨肉瘤(58.3%)的肿瘤细胞核呈强阳性反应。许多研究已证明,肿瘤细胞中p53蛋白的这种过度表达与p53基因突变有关。对骨肉瘤进行的DNA流式细胞术对比研究表明,大多数p53强阳性肿瘤的DNA指数值高于阴性或弱阳性肿瘤,尽管两组之间无统计学差异。还对骨肉瘤进行了p53基因的Southern印迹杂交。20例中有5例(20%)发生了p53基因的结构改变。其中3例为基因部分或全部缺失。2例有额外条带,表明基因重排。